UB Paderborn / Katalog / Suche / in CDI

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma[S]

Molecular & cellular proteomics, 2019-06, Vol.18 (6), p.1255-1268

2019

Volltextzugriff (PDF)

PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53

Clinical cancer research, 2011-05, Vol.17 (9), p.2830-2841

2011

Volltextzugriff (PDF)

Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

Molecular oncology, 2022-01, Vol.16 (1), p.206-218

2022

Volltextzugriff (PDF)

In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection

International journal of nanomedicine, 2010-01, Vol.5 (default), p.371-383

2010

Volltextzugriff (PDF)

Hallmarks of glioblastoma: a systematic review

ESMO open, 2016-01, Vol.1 (6), p.e000144-e000144, Article e000144

2016

Volltextzugriff (PDF)

Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images

Scientific reports, 2022-11, Vol.12 (1), p.19744-19744, Article 19744

2022

Volltextzugriff (PDF)

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)

Neuro-oncology (Charlottesville, Va.), 2019-12, Vol.21 (12), p.1595-1606

2019

Volltextzugriff (PDF)

Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy

Scientific reports, 2024-05, Vol.14 (1), p.10985-10985, Article 10985

2024

Volltextzugriff (PDF)

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Journal of neuro-oncology, 2018-05, Vol.137 (3), p.533-542

2018

Volltextzugriff (PDF)

Mechanisms for oncogenic activation of the epidermal growth factor receptor

Cellular signalling, 2007-10, Vol.19 (10), p.2013-2023

2007

Volltextzugriff (PDF)

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B

Molecular oncology, 2018-03, Vol.12 (3), p.406-420

2018

Volltextzugriff (PDF)

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

BMC cancer, 2013-09, Vol.13 (1), p.402-402, Article 402

2013

Volltextzugriff (PDF)

A prospective clinical study of the influence of oral protein intake on [18F]FET-PET uptake and test–retest repeatability in glioma

EJNMMI research, 2024-06, Vol.14 (1), p.58-14, Article 58

2024

Volltextzugriff (PDF)

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma

Frontiers in oncology, 2019-12, Vol.9, p.1425-1425

2019

Volltextzugriff (PDF)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Frontiers in oncology, 2020-04, Vol.10, p.478-478

2020

Volltextzugriff (PDF)

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

Frontiers in oncology, 2021-02, Vol.11, p.597587

2021

Volltextzugriff (PDF)

Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures

Cancer biology & therapy, 2013-07, Vol.14 (7), p.625-637

2013

Volltextzugriff (PDF)

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

International journal of molecular sciences, 2018-02, Vol.19 (3), p.679

2018

Volltextzugriff (PDF)

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

BMC cancer, 2017-04, Vol.17 (1), p.278-278, Article 278

2017

Volltextzugriff (PDF)

The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients

Neuro-oncology advances, 2023-01, Vol.5 (1), p.vdad137-vdad137

2023

Volltextzugriff (PDF)

Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial

Acta oncologica, 2017-01, Vol.56 (12), p.1776-1785

2017

Volltextzugriff (PDF)

Cell adhesion and EGFR activation regulate EphA2 expression in cancer

Cellular signalling, 2010-04, Vol.22 (4), p.636-644

2010

Volltextzugriff (PDF)

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

Molecular oncology, 2016-10, Vol.10 (8), p.1160-1168

2016

Volltextzugriff (PDF)

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Molecular oncology, 2020-05, Vol.14 (5), p.964-973

2020

Volltextzugriff (PDF)

Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI

Diagnostics (Basel), 2023-01, Vol.13 (3), p.363

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma[S]

PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53

Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection

Hallmarks of glioblastoma: a systematic review

Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)

Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Mechanisms for oncogenic activation of the epidermal growth factor receptor

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

A prospective clinical study of the influence of oral protein intake on [18F]FET-PET uptake and test–retest repeatability in glioma

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients

Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial

Cell adhesion and EGFR activation regulate EphA2 expression in cancer

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI

Suchergebnisse filtern